13 Einträge gefunden

1. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis

   1. Escala-Garcia, Maria
   2. Canisius, Sander
   3. Keeman, Renske
   4. Beesley, Jonathan
   5. Anton-Culver, Hoda
   6. Arndt, Volker
   7. Augustinsson, Annelie

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis

   1. Hartkopf, Andreas D
   2. Brucker, Sara Y
   3. Taran, Florin-Andrei
   4. Harbeck, Nadia
   5. von Au, Alexandra
   6. Naume, Bjørn
   7. Pierga, Jean-Yves

   2021 - Forschungsinformationssystem des UKE
3. Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"

   1. Schneeweiss, Andreas
   2. Ettl, Johannes
   3. Lüftner, Diana
   4. Beckmann, Matthias W
   5. Belleville, Erik
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Challenges and Opportunities for Real-World Evidence in Metastatic Luminal Breast Cancer

   1. Lüftner, Diana
   2. Hartkopf, Andreas D
   3. Lux, Michael P
   4. Overkamp, Friedrich
   5. Tesch, Hans
   6. Titzmann, Adriana
   7. Pöschke, Patrik

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. Gynecologists' attitudes toward and use of complementary and integrative medicine approaches: results of a national survey in Germany

   1. Grimm, Donata
   2. Voiss, Petra
   3. Paepke, Daniela
   4. Dietmaier, Johanna
   5. Cramer, Holger
   6. Kümmel, Sherko
   7. Beckmann, Matthias W

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
6. Diagnosis and Treatment of Endometriosis. Guideline of the DGGG, SGGG and OEGGG (S2k Level, AWMF Registry Number 015/045, August 2020)

   1. Burghaus, Stefanie
   2. Schäfer, Sebastian D
   3. Beckmann, Matthias W
   4. Brandes, Iris
   5. Brünahl, Christian
   6. Chvatal, Radek
   7. Drahoňovský, Jan

   2021 - Forschungsinformationssystem des UKE
7. Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

   1. Schneeweiss, Andreas
   2. Ettl, Johannes
   3. Lüftner, Diana
   4. Beckmann, Matthias W
   5. Belleville, Erik
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2020 - Forschungsinformationssystem des UKE
8. Identification of nine new susceptibility loci for endometrial cancer

   1. O'Mara, Tracy A
   2. Glubb, Dylan M
   3. Amant, Frederic
   4. Annibali, Daniela
   5. Ashton, Katie
   6. Attia, John
   7. Auer, Paul L

   2018 - Forschungsinformationssystem des UKE
9. Prevalence of circulating tumor cells in early breast cancer patients 2 and 5 years after adjuvant treatment

   1. Bauer, Emanuel C A
   2. Schochter, Fabienne
   3. Widschwendter, Peter
   4. DeGregorio, Amelie
   5. Andergassen, Ulrich
   6. Friedl, Thomas W P
   7. Fasching, Peter A

   2018 - Forschungsinformationssystem des UKE
10. Reproductive profiles and risk of breast cancer subtypes:a multi-center case-only study

    1. Brouckaert, Olivier
    2. Rudolph, Anja
    3. Laenen, Annouschka
    4. Keeman, Renske
    5. Bolla, Manjeet K
    6. Wang, Qin
    7. Soubry, Adelheid

    2017 - Forschungsinformationssystem des UKE
11. Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium

    1. Barrdahl, Myrto
    2. Rudolph, Anja
    3. Hopper, John L
    4. Southey, Melissa C
    5. Broeks, Annegien
    6. Fasching, Peter A
    7. Beckmann, Matthias W

    2017 - Forschungsinformationssystem des UKE
12. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci

    1. Kar, Siddhartha P
    2. Adler, Emily
    3. Tyrer, Jonathan
    4. Hazelett, Dennis J
    5. Anton-Culver, Hoda
    6. Bandera, Elisa V
    7. Beckmann, Matthias W

    2017 - Forschungsinformationssystem des UKE
13. HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer

    1. Harbeck, Nadia
    2. Beckmann, Matthias W
    3. Rody, Achim
    4. Schneeweiss, Andreas
    5. Müller, Volkmar
    6. Fehm, Tanja
    7. Marschner, Norbert

    2013 - Forschungsinformationssystem des UKE